These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38838784)
1. PEG length effect of peptide-functional liposome for blood brain barrier (BBB) penetration and brain targeting. Du Q; Liu Y; Fan M; Wei S; Ismail M; Zheng M J Control Release; 2024 Aug; 372():85-94. PubMed ID: 38838784 [TBL] [Abstract][Full Text] [Related]
3. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery. Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902 [TBL] [Abstract][Full Text] [Related]
4. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma. Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456 [TBL] [Abstract][Full Text] [Related]
5. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462 [TBL] [Abstract][Full Text] [Related]
6. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex. Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889 [TBL] [Abstract][Full Text] [Related]
7. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009 [TBL] [Abstract][Full Text] [Related]
8. A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment. Zhang CX; Zhao WY; Liu L; Ju RJ; Mu LM; Zhao Y; Zeng F; Xie HJ; Yan Y; Lu WL Oncotarget; 2015 Oct; 6(32):32681-700. PubMed ID: 26418720 [TBL] [Abstract][Full Text] [Related]
9. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy. Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025 [TBL] [Abstract][Full Text] [Related]
10. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819 [TBL] [Abstract][Full Text] [Related]
11. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma. Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J J Control Release; 2019 Aug; 307():247-260. PubMed ID: 31252036 [TBL] [Abstract][Full Text] [Related]
12. Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier. Papademetriou I; Vedula E; Charest J; Porter T PLoS One; 2018; 13(10):e0205158. PubMed ID: 30300391 [TBL] [Abstract][Full Text] [Related]
13. The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles. Xin H; Sha X; Jiang X; Chen L; Law K; Gu J; Chen Y; Wang X; Fang X Biomaterials; 2012 Feb; 33(5):1673-81. PubMed ID: 22133551 [TBL] [Abstract][Full Text] [Related]
14. Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy. Fan R; Chuan D; Hou H; Chen H; Han B; Zhang X; Zhou L; Tong A; Xu J; Guo G Nanoscale; 2019 Jun; 11(23):11285-11304. PubMed ID: 31165845 [TBL] [Abstract][Full Text] [Related]
15. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells. Kim JS; Shin DH; Kim JS J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480 [TBL] [Abstract][Full Text] [Related]
16. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma. Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282 [TBL] [Abstract][Full Text] [Related]
17. Angiopep-2-modified calcium arsenite-loaded liposomes for targeted and pH-responsive delivery for anti-glioma therapy. Xu H; Li C; Wei Y; Zheng H; Zheng H; Wang B; Piao JG; Li F Biochem Biophys Res Commun; 2021 Apr; 551():14-20. PubMed ID: 33714754 [TBL] [Abstract][Full Text] [Related]
18. Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain. Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J J Pharmacol Exp Ther; 2020 Sep; 374(3):354-365. PubMed ID: 32561686 [TBL] [Abstract][Full Text] [Related]
19. Enhanced glioma targeting and penetration by dual-targeting liposome co-modified with T7 and TAT. Zong T; Mei L; Gao H; Shi K; Chen J; Wang Y; Zhang Q; Yang Y; He Q J Pharm Sci; 2014 Dec; 103(12):3891-3901. PubMed ID: 25339554 [TBL] [Abstract][Full Text] [Related]
20. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery. Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]